Back to CBIO

WELLINGTON MANAGEMENT GROUP LLP → CBIO

WELLINGTON MANAGEMENT GROUP LLP CBIO Position History

Crescent Biopharma, Inc. • Healthcare

Quarters held
8
Latest value
$627K
Q3 2026
Peak value
$1.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$1.3M
Q4 2025$50K
Q4 2025$314K
Q2 2026$85K
Q2 2026$178K
Q3 2026$379K
Q3 2026$61K
Q3 2026$627K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$627K43.0K——
Q3 2026$61K4.2K——
Q3 2026$379K26.0K——
Q2 2026$178K9.9K——
Q2 2026$85K4.7K——
Q4 2025$314K27.7K——
Q4 2025$50K4.4K——
Q4 2025$1.3M111.3K——

Other funds holding CBIO

Other WELLINGTON MANAGEMENT GROUP LLP positions

NVDA

NVIDIA CORPORATION

$23.3B
MSFT

MICROSOFT CORP

$23.2B
NVDA

NVIDIA CORPORATION

$22.3B
NVDA

NVIDIA CORPORATION

$20.9B
MSFT

MICROSOFT CORP

$20.4B
NVDA

NVIDIA CORPORATION

$20B
AAPL

APPLE INC

$18.2B
AAPL

APPLE INC

$18.2B